Cognis Nutrition & Health announced today the launch of its first vegetarian lutein esters beadlet, Xangold® 10% GFB, a natural-source eye health ingredient with manufacturing advantages for nutritional supplement and dry food formulators worldwide.
“Xangold® 10% GFB will appeal to customers looking for one ingredient that will easily fit a range of needs from a manufacturing standpoint, with a consumer-friendly list of added benefits,” said Carrie Potaczek, Xangold® Product Manager. Xangold® 10% GFB natural lutein esters are kosher, gelatin-free, non-GMO, GRAS (Generally Recognized As Safe) beadlets. “These product features make Xangold® 10% GFB the beadlet of choice for the burgeoning vegetarian market.”
The hallmark of the new Xangold® 10% GFB is its first-rate stability. “Cognis’ innovative beadlet technology produces uniform, spherical particles designed to withstand the rigors of tableting and encapsulation. That means less overage and more space in the formulation,“ Ms. Potaczek explained.
A growing body of evidence supports the role of lutein ester supplementation in maintaining healthy vision as we age. Age-related macular degeneration (AMD) and cataracts are the leading causes of visual loss and blindness affecting millions of aging adults worldwide. Fortunately, carotenoids found in Xangold® natural lutein esters are showing promise to help enhance eye health. Research has shown that lutein and zeaxanthin, the only carotenoids found in the retina and lens of the eye, may act as antioxidants and filters to protect the eye from oxidative damage over a lifetime of exposure to harmful light. Xangold® natural lutein esters are an excellent, bioavailable source of lutein.
Cognis has petitioned the US Federal Food and Drug Administration (FDA) for a qualified health claim (QHC) linking consumption of Xangold® natural lutein esters to a reduced risk of AMD and cataracts. The FDA is slated to respond to Cognis’ petition on May 6.
About Xangold® Natural Lutein Esters
Xangold® natural lutein esters, extracted from marigold flowers that are grown specifically for Cognis, are available in two forms suitable for foods and nutritional supplements: 15% oil for soft gel capsules and oil based food products, and 10% microencapsulated beadlets for tablets or dry foods. Both forms are available in IP-certified, non-GM grades. Xangold®, which was the first source of lutein to complete the Generally Recognized As Safe (GRAS) notification process in January 2003, is the natural ingredient of choice for successful eye health products, offering excellent bioavailability and stability.
For information in Europe, call +49 2173 4995 116, e-mail [email protected], or fax +49 2112006-10116.
For information in Asia Pacific, call +61.3.9584.4588, e-mail [email protected], or fax +61.3.9584.8348.
Cognis (www.cognis.com) is a worldwide supplier of innovative specialty chemicals and nutritional ingredients. It employs 8,100 people, and has production sites and service centers in 30 countries. Cognis has dedicated its activities to a high level of sustainability and delivers natural source raw materials and ingredients for food, nutrition and healthcare markets, and the cosmetics, detergents and cleaners industries. Additionally, Cognis provides solutions for a number of other industries, such as coatings and inks, lubricants, textiles and plastics, as well as agriculture and mining. Cognis is owned by private equity funds advised by Permira, GS Capital Partners, and Schroder Ventures Life Sciences. In 2003, Cognis recorded sales of 2.95 billion euros and an Adjusted EBITDA (earnings before interest, income taxes, depreciation, amortization and exceptional items) of 312 million euros.
Caron Blitz, BLITZ + Associates, Inc.
847/945-0101 - voice
847/945-0606 - fax